Evaluating a multifaceted implementation strategy and package of evidence-based interventions based on WHO PEN for people living with HIV and cardiometabolic conditions in Lusaka, Zambia: protocol for the TASKPEN hybrid effectiveness-implementation stepped wedge cluster randomized trial.

Diabetes Dyslipidemia HIV/AIDS Hybrid effectiveness-implementation trial Hypertension Integration Non-communicable diseases Stepped-wedge trial Task shifting Zambia

Journal

Implementation science communications
ISSN: 2662-2211
Titre abrégé: Implement Sci Commun
Pays: England
ID NLM: 101764360

Informations de publication

Date de publication:
06 Jun 2024
Historique:
received: 31 03 2024
accepted: 28 05 2024
medline: 7 6 2024
pubmed: 7 6 2024
entrez: 6 6 2024
Statut: epublish

Résumé

Despite increasing morbidity and mortality from non-communicable diseases (NCD) globally, health systems in low- and middle-income countries (LMICs) have limited capacity to address these chronic conditions, particularly in sub-Saharan Africa (SSA). There is an urgent need, therefore, to respond to NCDs in SSA, beginning by applying lessons learned from the first global response to any chronic disease-HIV-to tackle the leading cardiometabolic killers of people living with HIV (PLHIV). We have developed a feasible and acceptable package of evidence-based interventions and a multi-faceted implementation strategy, known as "TASKPEN," that has been adapted to the Zambian setting to address hypertension, diabetes, and dyslipidemia. The TASKPEN multifaceted implementation strategy focuses on reorganizing service delivery for integrated HIV-NCD care and features task-shifting, practice facilitation, and leveraging HIV platforms for NCD care. We propose a hybrid type II effectiveness-implementation stepped-wedge cluster randomized trial to evaluate the effects of TASKPEN on clinical and implementation outcomes, including dual control of HIV and cardiometabolic NCDs, as well as quality of life, intervention reach, and cost-effectiveness. The trial will be conducted in 12 urban health facilities in Lusaka, Zambia over a 30-month period. Clinical outcomes will be assessed via surveys with PLHIV accessing routine HIV services, and a prospective cohort of PLHIV with cardiometabolic comorbidities nested within the larger trial. We will also collect data using mixed methods, including in-depth interviews, questionnaires, focus group discussions, and structured observations, and estimate cost-effectiveness through time-and-motion studies and other costing methods, to understand implementation outcomes according to Proctor's Outcomes for Implementation Research, the Consolidated Framework for Implementation Research, and selected dimensions of RE-AIM. Findings from this study will be used to make discrete, actionable, and context-specific recommendations in Zambia and the region for integrating cardiometabolic NCD care into national HIV treatment programs. While the TASKPEN study focuses on cardiometabolic NCDs in PLHIV, the multifaceted implementation strategy studied will be relevant to other NCDs and to people without HIV. It is expected that the trial will generate new insights that enable delivery of high-quality integrated HIV-NCD care, which may improve cardiovascular morbidity and viral suppression for PLHIV in SSA. This study was registered at ClinicalTrials.gov (NCT05950919).

Sections du résumé

BACKGROUND BACKGROUND
Despite increasing morbidity and mortality from non-communicable diseases (NCD) globally, health systems in low- and middle-income countries (LMICs) have limited capacity to address these chronic conditions, particularly in sub-Saharan Africa (SSA). There is an urgent need, therefore, to respond to NCDs in SSA, beginning by applying lessons learned from the first global response to any chronic disease-HIV-to tackle the leading cardiometabolic killers of people living with HIV (PLHIV). We have developed a feasible and acceptable package of evidence-based interventions and a multi-faceted implementation strategy, known as "TASKPEN," that has been adapted to the Zambian setting to address hypertension, diabetes, and dyslipidemia. The TASKPEN multifaceted implementation strategy focuses on reorganizing service delivery for integrated HIV-NCD care and features task-shifting, practice facilitation, and leveraging HIV platforms for NCD care. We propose a hybrid type II effectiveness-implementation stepped-wedge cluster randomized trial to evaluate the effects of TASKPEN on clinical and implementation outcomes, including dual control of HIV and cardiometabolic NCDs, as well as quality of life, intervention reach, and cost-effectiveness.
METHODS METHODS
The trial will be conducted in 12 urban health facilities in Lusaka, Zambia over a 30-month period. Clinical outcomes will be assessed via surveys with PLHIV accessing routine HIV services, and a prospective cohort of PLHIV with cardiometabolic comorbidities nested within the larger trial. We will also collect data using mixed methods, including in-depth interviews, questionnaires, focus group discussions, and structured observations, and estimate cost-effectiveness through time-and-motion studies and other costing methods, to understand implementation outcomes according to Proctor's Outcomes for Implementation Research, the Consolidated Framework for Implementation Research, and selected dimensions of RE-AIM.
DISCUSSION CONCLUSIONS
Findings from this study will be used to make discrete, actionable, and context-specific recommendations in Zambia and the region for integrating cardiometabolic NCD care into national HIV treatment programs. While the TASKPEN study focuses on cardiometabolic NCDs in PLHIV, the multifaceted implementation strategy studied will be relevant to other NCDs and to people without HIV. It is expected that the trial will generate new insights that enable delivery of high-quality integrated HIV-NCD care, which may improve cardiovascular morbidity and viral suppression for PLHIV in SSA. This study was registered at ClinicalTrials.gov (NCT05950919).

Identifiants

pubmed: 38844992
doi: 10.1186/s43058-024-00601-z
pii: 10.1186/s43058-024-00601-z
doi:

Banques de données

ClinicalTrials.gov
['NCT05950919']

Types de publication

Journal Article

Langues

eng

Pagination

61

Subventions

Organisme : NHLBI NIH HHS
ID : 5UH3HL156389
Pays : United States

Informations de copyright

© 2024. The Author(s).

Références

WHO. Preventing chronic disease: A vital investment. Geneva: World Health Organization; 2005.
WHO. Non-communicable diseases Fact Sheet: World Health Organization (WHO); 2023. Available from: https://www.who.int/news-room/fact-sheets/detail/noncommunicable-diseases .
Levitt NS, Steyn K, Dave J, Bradshaw D. Chronic noncommunicable diseases and HIV-AIDS on a collision course: relevance for health care delivery, particularly in low-resource settings–insights from South Africa. Am J Clin Nutr. 2011;94(6):1690S-S1696.
doi: 10.3945/ajcn.111.019075 pubmed: 22089433 pmcid: 3226022
Mukanu MM, Zulu JM, Mweemba C, Mutale W. Responding to non-communicable diseases in Zambia: a policy analysis. Health Res Policy Syst. 2017;15(1):34.
doi: 10.1186/s12961-017-0195-7 pubmed: 28438177 pmcid: 5402674
Mutale W, Bosomprah S, Shankalala P, Mweemba O, Chilengi R, Kapambwe S, et al. Assessing capacity and readiness to manage NCDs in primary care setting: Gaps and opportunities based on adapted WHO PEN tool in Zambia. PLoS ONE. 2018;13(8): e0200994.
doi: 10.1371/journal.pone.0200994 pubmed: 30138318 pmcid: 6107121
Bigna JJ, Ndoadoumgue AL, Nansseu JR, Tochie JN, Nyaga UF, Nkeck JR, et al. Global burden of hypertension among people living with HIV in the era of increased life expectancy: a systematic review and meta-analysis. J Hypertens. 2020;38(9):1659–68.
doi: 10.1097/HJH.0000000000002446 pubmed: 32371769
Bigna JJ, Noubiap JJ. Global burden of hypertension in people living with HIV. BMC Med. 2021;19(1):112.
doi: 10.1186/s12916-021-01981-y pubmed: 33985500 pmcid: 8120709
Mulenga LB, Musonda P, Chirwa L, Siwingwa M, Mweemba A, Suwilanji S, et al. Insulin Resistance is Associated with Higher Plasma Viral Load Among HIV-Positive Adults Receiving Longer-Term (1 Year) Combination Antiretroviral Therapy (ART). J Infect Dis Ther. 2019;7(4).
Peer N, Nguyen KA, Hill J, Sumner AE, Cikomola JC, Nachega JB, et al. Prevalence and influences of diabetes and prediabetes among adults living with HIV in Africa: a systematic review and meta-analysis. J Int AIDS Soc. 2023;26(3): e26059.
doi: 10.1002/jia2.26059 pubmed: 36924213 pmcid: 10018386
Murata H, Hruz PW, Mueckler M. The mechanism of insulin resistance caused by HIV protease inhibitor therapy. J Biol Chem. 2000;275(27):20251–4.
doi: 10.1074/jbc.C000228200 pubmed: 10806189
Pry JM, Bolton-Moore C, Sharma A, Wandeler G, Vera J. Prevalence and predictors of hypertension in aging people living with HIV attending care in Zambia. 11th International AIDS Society Conference on HIV Science; Berlin, Germany. 2021.
Teede H, Deeks A, Moran L. Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan. BMC Med. 2010;8:41.
doi: 10.1186/1741-7015-8-41 pubmed: 20591140 pmcid: 2909929
Thompson-Paul AM, Wei SC, Mattson CL, Robertson M, Hernandez-Romieu AC, Bell TK, et al. Obesity among HIV-infected adults receiving medical care in the United States: data from the cross-sectional medical monitoring project and national health and nutrition examination survey. Medicine (Baltimore). 2015;94(27):e1081-e.
doi: 10.1097/MD.0000000000001081
WHO. CVD Risk Management Package for low-and medium-Resource Settings. Geneva: World Health Organization; 2002. WHO; 2002.
Labhardt ND, Balo J-R, Ndam M, Grimm J-J, Manga E. Task shifting to non-physician clinicians for integrated management of hypertension and diabetes in rural Cameroon: a programme assessment at two years. BMC Health Serv Res. 2010;10:339.
doi: 10.1186/1472-6963-10-339 pubmed: 21144064 pmcid: 3018451
Mendis S, Johnston SC, Fan W, Oladapo O, Cameron A, Faramawi MF. Cardiovascular risk management and its impact on hypertension control in primary care in low-resource settings: a cluster-randomized trial. Bull World Health Organ. 2010;88(6):412–9.
doi: 10.2471/BLT.08.062364 pubmed: 20539854
Chamie G, Kwarisiima D, Clark TD, Kabami J, Jain V, Geng E, et al. Leveraging Rapid Community-Based HIV Testing Campaigns for Non-Communicable Diseases in Rural Uganda. PLoS ONE. 2012;7(8):e43400.
doi: 10.1371/journal.pone.0043400 pubmed: 22916256 pmcid: 3423366
Kavishe B, Biraro S, Baisley K, Vanobberghen F, Kapiga S, Munderi P, et al. High prevalence of hypertension and of risk factors for non-communicable diseases (NCDs): a population based cross-sectional survey of NCDS and HIV infection in Northwestern Tanzania and Southern Uganda. BMC medicine. 2015;13:126.
doi: 10.1186/s12916-015-0357-9 pubmed: 26021319 pmcid: 4476208
Khabala KB, Edwards JK, Baruani B, Sirengo M, Musembi P, Kosgei RJ, et al. Medication Adherence Clubs: a potential solution to managing large numbers of stable patients with multiple chronic diseases in informal settlements. Trop Med Int Health. 2015;20(10):1265–70.
doi: 10.1111/tmi.12539 pubmed: 25962952 pmcid: 4744994
Wroe EB, Kalanga N, Mailosi B, Mwalwanda S, Kachimanga C, Nyangulu K, et al. Leveraging HIV platforms to work toward comprehensive primary care in rural Malawi: the Integrated Chronic Care Clinic. Healthcare. 2015;3(4):270–6.
doi: 10.1016/j.hjdsi.2015.08.002 pubmed: 26699356
MatanjeMwagomba BL, Ameh S, Bongomin P, Juma PA, MacKenzie RK, Kyobutungi C, et al. Opportunities and challenges for evidence-informed HIV-noncommunicable disease integrated care policies and programs: lessons from Malawi, South Africa Swaziland and Kenya. AIDS. 2018;32:S21–32.
doi: 10.1097/QAD.0000000000001885
Lekoubou A, Awah P, Fezeu L, Sobngwi E, Kengne AP. Hypertension, diabetes mellitus and task shifting in their management in sub-Saharan Africa. Int J Environ Res Public Health. 2010;7(2):353–63.
doi: 10.3390/ijerph7020353 pubmed: 20616978 pmcid: 2872286
World Medical Association Resolution on task shifting from the medical profession. World Medical Association; 2019. Available from: https://www.wma.net/policies-post/wma-resolution-on-task-shifting-from-the-medical-profession/ . Accessed 29 Nov 2020.
Zachariah R, Ford N, Philips M, S.Lynch, Massaquoi M, Janssens V, et al. Task shifting in HIV/AIDS: opportunities, challenges and proposed actions for sub-Saharan Africa. Trans Royal Soc Trop Med Hyg. 2009;103(6):549–58.
Ogedegbe G, Tobin JN, Fernandez S, Gerin W, Diaz-Gloster M, Cassells A, et al. Counseling African Americans to Control Hypertension (CAATCH) trial: a multi-level intervention to improve blood pressure control in hypertensive blacks. Circ Cardiovasc Qual Outcomes. 2009;2(3):249–56.
doi: 10.1161/CIRCOUTCOMES.109.849976 pubmed: 20031845 pmcid: 2800792
Njuguna B, Vorkoper S, Patel P, Reid MJA, Vedanthan R, Pfaff C, et al. Models of integration of HIV and noncommunicable disease care in sub-Saharan Africa: lessons learned and evidence gaps. Aids. 2018;32 Suppl 1(Suppl 1):S33-s42.
Rogers HE, Akiteng AR, Mutungi G, Ettinger AS, Schwartz JI. Capacity of Ugandan public sector health facilities to prevent and control non-communicable diseases: an assessment based upon WHO-PEN standards. BMC Health Serv Res. 2018;18(1):606.
doi: 10.1186/s12913-018-3426-x pubmed: 30081898 pmcid: 6080524
Zhang XH, Lisheng L, Campbell NR, Niebylski ML, Nilsson P, Lackland DT. Implementation of World Health Organization Package of Essential Noncommunicable Disease Interventions (WHO PEN) for Primary Health Care in Low-Resource Settings: A Policy Statement From the World Hypertension League. J Clin Hypertens (Greenwich). 2016;18(1):5–6.
doi: 10.1111/jch.12749 pubmed: 26646424
Moomba K, Williams A, Savory T, Lumpa M, Chilembo P, Tweya H, et al. Effects of real-time electronic data entry on HIV programme data quality in Lusaka. Zambia Public Health Action. 2020;10(1):47–52.
doi: 10.5588/pha.19.0068 pubmed: 32368524
Tesema AG, Ajisegiri WS, Abimbola S, Balane C, Kengne AP, Shiferaw F, et al. How well are non-communicable disease services being integrated into primary health care in Africa: A review of progress against World Health Organization’s African regional targets. PLoS ONE. 2020;15(10): e0240984.
doi: 10.1371/journal.pone.0240984 pubmed: 33091037 pmcid: 7580905
Proctor EK, Powell BJ, McMillen JC. Implementation strategies: recommendations for specifying and reporting. Implementation Sci. 2013;8:139.
Warner G, Lawson B, Sampalli T, Burge F, Gibson R, Wood S. Applying the consolidated framework for implementation research to identify barriers affecting implementation of an online frailty tool into primary health care: a qualitative study. BMC Health Serv Res. 2018;18(1):395.
doi: 10.1186/s12913-018-3163-1 pubmed: 29855306 pmcid: 5984376
Damschroder LJ, Aron DC, Keith RE, Kirsh SR, Alexander JA, Lowery JC. Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science. Implement Sci. 2009;4:50.
doi: 10.1186/1748-5908-4-50 pubmed: 19664226 pmcid: 2736161
Glasgow RE, Vogt TM, Boles SM. Evaluating the public health impact of health promotion interventions: the RE-AIM framework. Am J Public Health. 1999;89(9):1322–7.
doi: 10.2105/AJPH.89.9.1322 pubmed: 10474547 pmcid: 1508772
Glasgow RE, Estabrooks PE. Pragmatic Applications of RE-AIM for Health Care Initiatives in Community and Clinical Settings. Prev Chronic Dis. 2018;15:E02.
doi: 10.5888/pcd15.170271 pubmed: 29300695 pmcid: 5757385
Smith JD, Li DH, Rafferty MR. The Implementation Research Logic Model: a method for planning, executing, reporting, and synthesizing implementation projects. Implement Sci. 2020;15:84.
WHO. HEARTS Technical package for cardiovascular disease management in primary health care: evidence-based treatment protocols. Geneva: World Health Organization (WHO); 2018. Contract No.: 2018 (WHO/NMH/NVI/18.2).
Tateyama Y, Techasrivichien T, Musumari PM, Suguimoto SP, Ongosi AN, Zulu R, et al. Hypertension, its correlates and differences in access to healthcare services by gender among rural Zambian residents: a cross-sectional study. BMJ Open. 2022;12(4): e055668.
doi: 10.1136/bmjopen-2021-055668 pubmed: 35396290 pmcid: 8996044
Unger T, Borghi C, Charchar F, Khan NA, Poulter NR, Prabhakaran D, et al. 2020 International Society of Hypertension Global Hypertension Practice Guidelines. Hypertension. 2020;75(6):1334–57.
doi: 10.1161/HYPERTENSIONAHA.120.15026 pubmed: 32370572
IAPAC. IAPAC Protocols for the Integrated Management of HIV and Noncommunicable Diseases. Washington, D.C. : International Association of Providers of AIDS Care (IAPAC) 2018.
Bauer S, Wa Mwanza M, Chilengi R, Holmes CB, Zyambo Z, Furrer H, et al. Awareness and management of elevated blood pressure among human immunodeficiency virus-infected adults receiving antiretroviral therapy in urban Zambia: a call to action. Glob Health Action. 2017;10(1):1359923.
Limbada M, Macleod D, Situmbeko V, Muhau E, Shibwela O, Chiti B, et al. Rates of viral suppression in a cohort of people with stable HIV from two community models of ART delivery versus facility-based HIV care in Lusaka, Zambia: a cluster-randomised, non-inferiority trial nested in the HPTN 071 (PopART) trial. Lancet HIV. 2022;9(1):e13–23.
doi: 10.1016/S2352-3018(21)00242-3 pubmed: 34843674
Hamooya BM, Musonda P, Mutale W, Masenga SK, Halwiindi H, Mutengo KH, et al. Prevalence of low high-density lipoprotein among young adults receiving antiretroviral therapy in Zambia: An opportunity to consider non-communicable diseases in resource-limited settings. PLoS ONE. 2021;16(2):e0247004.
doi: 10.1371/journal.pone.0247004 pubmed: 33592027 pmcid: 7886128
Mweemba P, Zeller R, Ludwick R, Gosnell D, Michelo C. Validation of the World Health Organization Quality of Life HIV instrument in a Zambian sample. J Assoc Nurs AIDS Care. 2011;22(1):53–66.
doi: 10.1016/j.jana.2010.04.006
Nevo D, Lok JJ, Spiegelman D. Analysis of “Learn-as-You-Go” (Lago) Studies. Ann Stat. 2021;49(2):793–819.
doi: 10.1214/20-AOS1978 pubmed: 35510045 pmcid: 9067111
Varsi C, Ekstedt M, Gammon D, Ruland CM. Using the Consolidated Framework for Implementation Research to Identify Barriers and Facilitators for the Implementation of an Internet-Based Patient-Provider Communication Service in Five Settings: A Qualitative Study. J Med Internet Res. 2015;17(11):e262-e.
Weiner BJ, Lewis CC, Stanick C, Powell BJ, Dorsey CN, Clary AS, et al. Psychometric assessment of three newly developed implementation outcome measures. Implement Sci. 2017;12(1):108.
doi: 10.1186/s13012-017-0635-3 pubmed: 28851459 pmcid: 5576104
Proctor E, Silmere H, Raghavan R, Hovmand P, Aarons G, Bunger A, et al. Outcomes for implementation research: conceptual distinctions, measurement challenges, and research agenda. Administration and policy in mental health. 2011;38(2):65-76.
Institute for Health Metrics and Evaluation (IHME). Global Burden of Disease Study 2015 (GBD 2015) Disability Weights Institute for Health Metrics and Evaluation, Seattle, Washington, 2015. Available from: http://ghdx.healthdata.org/record/global-burden-disease-study-2015-gbd-2015-disability-weights .
Janssens B, Van Damme W, Raleigh B, Gupta J, Khem S, Soy Ty K, et al. Offering integrated care for HIV/AIDS, diabetes and hypertension within chronic disease clinics in Cambodia. Bulletin of the World Health Organization. 2007;85(11):880-5.
Kar SS, Thakur JS, Jain S, Kumar R. Cardiovascular disease risk management in a primary health care setting of north India. Indian Heart J. 2008;60(1):19–25.
pubmed: 19212017
Ajay VS, Jindal D, Roy A, Venugopal V, Sharma R, Pawar A, et al. Development of a Smartphone-Enabled Hypertension and Diabetes Mellitus Management Package to Facilitate Evidence-Based Care Delivery in Primary Healthcare Facilities in India: The mPower Heart Project. J Am Heart Assoc. 2016;5(12).
Ogedegbe G, Plange-Rhule J, Gyamfi J, Chaplin W, Ntim M, Apusiga K, et al. Health insurance coverage with or without a nurse-led task shifting strategy for hypertension control: A pragmatic cluster randomized trial in Ghana. PLoS Med. 2018;15(5): e1002561.
doi: 10.1371/journal.pmed.1002561 pubmed: 29715303 pmcid: 5929500
Nelissen HE, Cremers AL, Okwor TJ, Kool S, van Leth F, Brewster L, et al. Pharmacy-based hypertension care employing mHealth in Lagos, Nigeria - a mixed methods feasibility study. BMC Health Serv Res. 2018;18(1):934.
doi: 10.1186/s12913-018-3740-3 pubmed: 30514376 pmcid: 6277995

Auteurs

Michael E Herce (ME)

Centre for Infectious Disease Research in Zambia (CIDRZ), Lusaka, Zambia. michael.herce@cidrz.org.
Institute for Global Health and Infectious Diseases, University of North Carolina, Chapel Hill, NC, USA. michael.herce@cidrz.org.

Samuel Bosomprah (S)

Centre for Infectious Disease Research in Zambia (CIDRZ), Lusaka, Zambia.
Department of Biostatistics, School of Public Health, University of Ghana, Accra, Ghana.

Felix Masiye (F)

Department of Health Economics, School of Public Health, University of Zambia, Ridgeway Campus, Lusaka, Zambia.

Oliver Mweemba (O)

Department of Health Promotion and Education, School of Public Health, University of Zambia, Ridgeway Campus, Lusaka, Zambia.

Jessie K Edwards (JK)

Department of Epidemiology, University of North Carolina, Chapel Hill, NC, USA.

Chomba Mandyata (C)

Centre for Infectious Disease Research in Zambia (CIDRZ), Lusaka, Zambia.

Mmamulatelo Siame (M)

Centre for Infectious Disease Research in Zambia (CIDRZ), Lusaka, Zambia.
Department of Paediatrics and Child Health, School of Medicine, University of Zambia, Lusaka, Zambia.

Chilambwe Mwila (C)

Centre for Infectious Disease Research in Zambia (CIDRZ), Lusaka, Zambia.

Tulani Matenga (T)

Department of Health Promotion and Education, School of Public Health, University of Zambia, Ridgeway Campus, Lusaka, Zambia.

Christiana Frimpong (C)

Centre for Infectious Disease Research in Zambia (CIDRZ), Lusaka, Zambia.

Anchindika Mugala (A)

Centre for Infectious Disease Research in Zambia (CIDRZ), Lusaka, Zambia.
Department of Medicine, Division of Infectious Diseases, University Teaching Hospital, Lusaka, Zambia.

Peter Mbewe (P)

Centre for Infectious Disease Research in Zambia (CIDRZ), Lusaka, Zambia.

Perfect Shankalala (P)

Centre for Infectious Disease Research in Zambia (CIDRZ), Lusaka, Zambia.

Pendasambo Sichone (P)

Centre for Infectious Disease Research in Zambia (CIDRZ), Lusaka, Zambia.

Blessings Kasenge (B)

Centre for Infectious Disease Research in Zambia (CIDRZ), Lusaka, Zambia.

Luanaledi Chunga (L)

Centre for Infectious Disease Research in Zambia (CIDRZ), Lusaka, Zambia.

Rupert Adams (R)

Centre for Infectious Disease Research in Zambia (CIDRZ), Lusaka, Zambia.

Brian Banda (B)

Centre for Infectious Disease Research in Zambia (CIDRZ), Lusaka, Zambia.

Daniel Mwamba (D)

Centre for Infectious Disease Research in Zambia (CIDRZ), Lusaka, Zambia.

Namwinga Nachalwe (N)

Centre for Infectious Disease Research in Zambia (CIDRZ), Lusaka, Zambia.

Mansi Agarwal (M)

Institute of Public Health, School of Medicine, Washington University in St. Louis, St. Louis, MO, USA.

Makeda J Williams (MJ)

Center for Translation Research and Implementation Science, National Heart, Lung, and Blood Institute, U.S. National Institutes of Health, Bethesda, MD, USA.

Veronica Tonwe (V)

Center for Translation Research and Implementation Science, National Heart, Lung, and Blood Institute, U.S. National Institutes of Health, Bethesda, MD, USA.

Jake M Pry (JM)

Centre for Infectious Disease Research in Zambia (CIDRZ), Lusaka, Zambia.
Department of Epidemiology, School of Medicine, University of California at Davis, Davis, CA, USA.

Maurice Musheke (M)

Centre for Infectious Disease Research in Zambia (CIDRZ), Lusaka, Zambia.

Michael Vinikoor (M)

Centre for Infectious Disease Research in Zambia (CIDRZ), Lusaka, Zambia.
Division of Infectious Diseases, Department of Medicine, University of Alabama, Birmingham, AL, USA.

Wilbroad Mutale (W)

Centre for Infectious Disease Research in Zambia (CIDRZ), Lusaka, Zambia.
Department of Health Policy and Management, School of Public Health, University of Zambia, Lusaka, Zambia.

Classifications MeSH